GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (UKEX:MRK) » Definitions » Shiller PE Ratio

Merck (UKEX:MRK) Shiller PE Ratio : 37.27 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Merck Shiller PE Ratio?

As of today (2024-05-24), Merck's current share price is ₴4844.00. Merck's E10 for the quarter that ended in Mar. 2024 was ₴129.96. Merck's Shiller PE Ratio for today is 37.27.

The historical rank and industry rank for Merck's Shiller PE Ratio or its related term are showing as below:

UKEX:MRK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.86   Med: 26.91   Max: 39.37
Current: 37.03

During the past years, Merck's highest Shiller PE Ratio was 39.37. The lowest was 17.86. And the median was 26.91.

UKEX:MRK's Shiller PE Ratio is ranked worse than
70.73% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.7 vs UKEX:MRK: 37.03

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Mar. 2024 was ₴75.092. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₴129.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck Shiller PE Ratio Historical Data

The historical data trend for Merck's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Shiller PE Ratio Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.15 31.30 26.05 32.35 32.38

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.13 35.01 29.75 32.38 37.28

Competitive Comparison of Merck's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=4844.00/129.96
=37.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Merck's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=75.092/131.7762*131.7762
=75.092

Current CPI (Mar. 2024) = 131.7762.

Merck Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 27.306 100.560 35.783
201409 12.448 100.428 16.334
201412 101.997 99.070 135.670
201503 13.252 99.621 17.529
201506 9.637 100.684 12.613
201509 25.700 100.392 33.734
201512 14.055 99.792 18.560
201603 16.062 100.470 21.067
201606 17.267 101.688 22.376
201609 31.322 101.861 40.521
201612 16.866 101.863 21.819
201703 22.487 102.862 28.808
201706 28.511 103.349 36.353
201709 -0.803 104.136 -1.016
201712 -12.985 104.011 -16.451
201803 10.842 105.290 13.569
201806 25.298 106.317 31.356
201809 29.314 106.507 36.269
201812 27.708 105.998 34.446
201903 44.975 107.251 55.260
201906 41.361 108.070 50.434
201909 29.716 108.329 36.148
201912 36.944 108.420 44.903
202003 50.597 108.902 61.225
202006 47.384 108.767 57.408
202009 46.581 109.815 55.896
202012 -33.330 109.897 -39.966
202103 50.195 111.754 59.188
202106 24.495 114.631 28.159
202109 72.281 115.734 82.300
202112 59.431 117.630 66.578
202203 68.265 121.301 74.160
202206 62.242 125.017 65.607
202209 51.400 125.227 54.088
202212 47.384 125.222 49.864
202303 44.573 127.348 46.123
202306 -94.367 128.729 -96.601
202309 74.690 129.860 75.792
202312 -19.275 129.419 -19.626
202403 75.092 131.776 75.092

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck  (UKEX:MRK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Merck Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Merck's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (UKEX:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (UKEX:MRK) Headlines

From GuruFocus

Q2 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc To Host ESMO Call (Virtual) Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024